British researchers to test coronavirus vaccine on 10K People
British researchers testing an experimental coronavirus vaccine are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works. Last month, scientists at Oxford University began immunizing more than 1,000 volunteers with their vaccine candidate in a preliminary trial designed to test the shot’s safety, the AP reports.
vaccine oxford coronavirus
NewserRelated Articles
India reports 83,000 new coronavirus cases
India reports 83,000 new coronavirus cases
India recorded 83,341 COVID-19 cases in the last 24 hours along with 1,096 deaths. India’s total coronavirus cases passed 3.9 million, now just behind Brazil with 4 million cases. The US topped the list with more than 6 million coronavirus cases. India’s case fatality rate of 1.75% is well below the global average of 3.3%, the ministry said. Experts have questioned whether some Indian states have undercounted deaths
india deaths coronavirus covid19 cases covid
AP
India reports 76,000 new coronavirus cases
India reports 76,000 new coronavirus cases
India reported a new record of daily infections on Wednesday as more than 76,000 tested positive across the country. Simultaneously, fatalities also crossed 60,000 yesterday, which means the South Asian country has the fourth-highest death toll in the world. India has confirmed more than three million cases so far, with the latest million taking just 15 days to reach
india coronavirus covid19 cases
BBC
Here's Why Buying Coronavirus Stocks Can Be Risky
Here's Why Buying Coronavirus Stocks Can Be Risky
Many of the hottest stocks on the markets right now are those of companies developing potential vaccines or treatments for COVID-19, or businesses that are well-suited to the transformed economic conditions of the coronavirus pandemic. While new COVID-19 cases may continue to pop up for many years, investors shouldn't assume the pandemic is a long-term situation and ought to avoid investing based on that assumption.
vaccine heres risky
Fool
Novavax Launches Midstage Coronavirus Vaccine Trial
Novavax Launches Midstage Coronavirus Vaccine Trial
Vaccine specialist Novavax (NASDAQ:NVAX) announced the launch of a phase 2b clinical trial in South Africa to test the effectiveness of its coronavirus vaccine, NVX-CoV2373. Novavax is somewhat behind the leaders in the race for an approved vaccine for COVID-19, but the level of transmission in South Africa may give the company a chance to evaluate the efficacy of its vaccine very quickly.
vaccine novavax midstage
Fool